Xuan Zhang

14PUBLICATIONS
20CO-AUTHORS
Wastewater treatment processesMolecular targetsPredictive and prognostic markersBiomolecular modelling and designTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Nov 28, 2025
A Versatile Bioorthogonal Theranostic Platform Enables Relay Activation of Tumor Cell Imaging and Targeted Protein Degradation.

Feilong Sun, Tian Wang, Pengfei Wang

|Oct 25, 2025
Beyond Inhibition: Recent Advances of Heterobifunctional Molecules Targeting CDK9.

Junzhe Yin, Na Zhang, Tian Wang

|Jun 15, 2023
Recent Advances in Pro-PROTAC Development to Address On-Target Off-Tumor Toxicity.

Chuanjie Chen, Yiwen Yang, Zhe Wang

|Nov 26, 2021
Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity.

Dongwen Lv, Pratik Pal, Xingui Liu

|Jul 23, 2021
PROTACs are effective in addressing the platelet toxicity associated with BCL-XL inhibitors.

Peiyi Zhang, Xuan Zhang, Xingui Liu

Pageof 3